KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Cash & Current Investments (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Cash & Current Investments for 17 consecutive years, with $1.5 billion as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments fell 7.44% to $1.5 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.5 billion through Dec 2025, down 7.44% year-over-year, with the annual reading at $1.5 billion for FY2025, 7.44% down from the prior year.
  • Cash & Current Investments for Q4 2025 was $1.5 billion at Bio-Rad Laboratories, up from $1.4 billion in the prior quarter.
  • The five-year high for Cash & Current Investments was $2.1 billion in Q1 2022, with the low at $395.6 million in Q2 2023.
  • Average Cash & Current Investments over 5 years is $1.1 billion, with a median of $1.0 billion recorded in 2021.
  • Peak annual rise in Cash & Current Investments hit 306.57% in 2024, while the deepest fall reached 76.3% in 2024.
  • Over 5 years, Cash & Current Investments stood at $476.4 million in 2021, then dropped by 7.68% to $439.8 million in 2022, then fell by 6.91% to $409.4 million in 2023, then surged by 306.57% to $1.7 billion in 2024, then decreased by 7.44% to $1.5 billion in 2025.
  • According to Business Quant data, Cash & Current Investments over the past three periods came in at $1.5 billion, $1.4 billion, and $1.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.